PIN24 Cost-Benefit Analysis of Hospital Based Postpartum Vaccination With Combined Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (TDAP)
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1300
https://www.valueinhealthjournal.com/article/S1098-3015(12)01365-4/fulltext
Title :
PIN24 Cost-Benefit Analysis of Hospital Based Postpartum Vaccination With Combined Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (TDAP)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01365-4&doi=10.1016/j.jval.2012.03.1300
First page :
A241
Section Title :
Infection
Open access? :
No
Section Order :
832